间质干细胞市场规模、份额及成长分析（依产品、来源、适应症、应用及地区划分）－2026-2033年产业预测

全球间间质干细胞(MSC) 市场规模预计在 2024 年达到 40.5 亿美元，从 2025 年的 45.6 亿美元增长到 2033 年的 117.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 12.6%。

全球间间质干细胞(MSC) 市场正经历显着成长，这主要得益于其在再生医学、组织工程和免疫调节等领域公认的治疗应用。 MSC 具有分化为骨细胞、软骨细胞和脂肪细胞的能力，能够促进受损组织的修復和再生，使其成为临床研究的前沿领域。慢性疾病发生率的上升、对细胞疗法需求的增加以及在整形外科、神经科、肿瘤科和皮肤科等领域应用范围的扩大，都推动了这一增长。此外，干细胞库和生物製程技术的进步也促进了临床试验的核准，并支持了 MSC 的广泛应用。儘管 MSC 的应用仍面临伦理问题、规模化生产和监管障碍等挑战，但生物技术公司、研究机构和医疗服务提供者之间的合作对于市场扩张至关重要。

全球间质干细胞市场驱动因素

心血管疾病、骨关节炎、自体免疫疾病和神经系统疾病等慢性疾病发生率的不断上升，是全球间间质干细胞（MSC）市场的主要驱动力。 MSC因其具有再生受损组织和调节免疫反应的能力，被视为治疗这些健康挑战的一种极具前景的治疗方法。随着受影响人数的增加以及对创新再生疗法需求的成长，基于MSC的治疗方法预计将显着应用。这一趋势凸显了MSC在慢性病管理和再生医学领域中发挥的重要作用，尤其是在亟需有效解决方案的领域。

限制全球间质干细胞市场的因素

间质干细胞疗法研发和应用的高成本是限制市场成长的一大障碍。间质干细胞的生产需要专门的实验室、先进的设备和熟练的人员，以确保细胞的活力、纯度和无菌性。此外，细胞分离、扩增和冷冻保存等过程耗费大量资源和时间。这种复杂性增加了治疗成本，并给患者带来挑战，尤其是在医疗体係不发达的发展中地区。因此，儘管间质干细胞具有明显的治疗优势，但由于这些经济障碍，其广泛应用往往低于预期。

全球间质干细胞（MSC）市场趋势

全球间间质干细胞(MSC) 市场正经历着向再生医学和个人化医疗的动态转变，反映出人们对针对个别患者需求量身定制治疗方法的日益增长的需求。 MSC 具有修復和再生受损组织的独特能力，这推动了其在治疗多种疾病方面的应用，包括肌肉骨骼疾病、心血管疾病、神经系统疾病和自体免疫疾病。调查方法和生产技术的进步正在提高基于 MSC治疗方法的精准性和扩充性。此外，将预测模型和人工智慧应用于患者筛选和治疗方案製定，正在推动临床疗效的改善和副作用的减少，从而开启一个以患者独特健康需求为优先的个人化治疗方案的未来。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

全球间质干细胞市场规模（依产品及复合年增长率划分）（2026-2033 年）

• 细胞和细胞株
• 试剂盒、培养基和试剂
• 其他的

全球间质干细胞市场规模（依来源及复合年增长率划分）（2026-2033 年）

• 骨髓间间质干细胞
• 脂肪组织来源的间质干细胞
• 脐带/胎盘来源的间质干细胞
• 其他的

全球间质干细胞市场规模（按适应症和复合年增长率划分）（2026-2033 年）

• 骨/软骨修復
• 心血管疾病
• 发炎/免疫性疾病
• 肝病
• 癌症
• 移植物抗宿主疾病（GvHD）及其他适应症

全球间质干细胞市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 疾病模型
• 药物发现与开发
• 干细胞库
• 组织工程
• 毒理学研究

全球间间质干细胞市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific Inc.
• STEMCELL Technologies Inc.
• Merck KGaA
• Lonza Group Ltd.
• Cyagen Biosciences Inc.
• PromoCell GmbH
• Axol Bioscience Ltd.
• Cellcolabs Clinical Ltd.
• Cell Applications Inc.
• Mesoblast Ltd.
• Cynata Therapeutics
• Orgenesis Inc.
• Stempeutics Research Pvt. Ltd.
• BioRestorative Therapies
• ScienCell Research Laboratories Inc.
• Takara Bio Inc.
• Takara Bio Inc.
• BioTime Inc.
• PLURI Inc.
• Cell Tech Pharmed

结论与建议

Global Mesenchymal Stem Cells Market size was valued at USD 4.05 Billion in 2024 and is poised to grow from USD 4.56 Billion in 2025 to USD 11.79 Billion by 2033, growing at a CAGR of 12.6% during the forecast period (2026-2033).

The global mesenchymal stem cells (MSCs) market is witnessing significant growth driven by the recognition of their therapeutic applications in regenerative medicine, tissue engineering, and immunomodulation. With their ability to facilitate repair and regeneration of damaged tissues by differentiating into bone, cartilage, and fat cells, MSCs are at the forefront of clinical research. This growth is propelled by the rising incidence of chronic diseases, increasing demand for cell-based therapies, and expanded application areas in orthopedics, neurology, oncology, and dermatology. Furthermore, advancements in stem cell banking and bioprocessing technologies enhance clinical trial approvals, supporting widespread adoption. Collaborative efforts among biotech firms, research institutions, and healthcare providers are essential for market expansion, despite challenges related to ethical concerns, scaling, and regulatory hurdles in MSC applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mesenchymal Stem Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mesenchymal Stem Cells Market Segments Analysis

Global Mesenchymal Stem Cells Market is segmented by Product, Source, Indication, Application and region. Based on Product, the market is segmented into Cells & Cell Lines, Kits, Media & Reagents and Others. Based on Source, the market is segmented into Bone Marrow-derived MSCs, Adipose Tissue-derived MSCs, Umbilical Cord / Placental MSCs and Others. Based on Indication, the market is segmented into Bone & Cartilage Repair, Cardiovascular Diseases, Inflammatory & Immunological Diseases, Liver Diseases, Cancer and GvHD & Other Indications. Based on Application, the market is segmented into Disease Modeling, Drug Discovery & Development, Stem Cell Banking, Tissue Engineering and Toxicology Studies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mesenchymal Stem Cells Market

The increasing incidence of chronic conditions like cardiovascular issues, osteoarthritis, autoimmune disorders, and neurological diseases significantly fuels the global mesenchymal stem cells (MSCs) market. MSCs possess the ability to regenerate damaged tissues and influence the immune response, making them a promising therapeutic avenue for these health challenges. As the number of affected individuals rises and the demand for innovative regenerative treatments escalates, the adoption of MSC-based therapies is poised for substantial growth. This trend highlights the critical role of MSCs in addressing the urgent need for effective solutions in the realm of chronic disease management and regeneration.

Restraints in the Global Mesenchymal Stem Cells Market

The high costs associated with the development and administration of mesenchymal stem cell therapies significantly hinder market growth. Producing MSCs demands specialized laboratories, advanced equipment, and a skilled workforce to ensure the viability, purity, and sterility of the cells. Furthermore, the processes involved in cell isolation, expansion, and cryopreservation are resource-intensive and time-consuming. This complexity leads to elevated treatment expenses, posing a challenge for patients, particularly in developing regions where healthcare reimbursement may be lacking. Consequently, despite the evident therapeutic advantages of MSCs, their widespread adoption often lags behind expectations due to these financial barriers.

Market Trends of the Global Mesenchymal Stem Cells Market

The Global Mesenchymal Stem Cells (MSCs) market is experiencing a dynamic shift towards regenerative and personalized medicine, reflecting a growing preference for therapies tailored to individual patient needs. The intrinsic capabilities of MSCs in repairing and regenerating damaged tissues are driving their increased application in treating a range of conditions, including musculoskeletal, cardiovascular, neurological, and autoimmune disorders. Advances in research methodologies and manufacturing techniques are enhancing the precision and scalability of MSC-based therapies. Furthermore, the integration of predictive modeling and artificial intelligence in patient selection and therapy planning is fostering improved clinical outcomes and reduced side effects, heralding a future characterized by customized treatment approaches that prioritize patient-specific health needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Mesenchymal Stem Cells Market Size by Product & CAGR (2026-2033)

• Market Overview
• Cells & Cell Lines
• Kits, Media & Reagents
• Others

Global Mesenchymal Stem Cells Market Size by Source & CAGR (2026-2033)

• Market Overview
• Bone Marrow-derived MSCs
• Adipose Tissue-derived MSCs
• Umbilical Cord / Placental MSCs
• Others

Global Mesenchymal Stem Cells Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Bone & Cartilage Repair
• Cardiovascular Diseases
• Inflammatory & Immunological Diseases
• Liver Diseases
• Cancer
• GvHD & Other Indications

Global Mesenchymal Stem Cells Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Modeling
• Drug Discovery & Development
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies

Global Mesenchymal Stem Cells Market Size & CAGR (2026-2033)

• North America (Product, Source, Indication, Application)
  • US
  • Canada
• Europe (Product, Source, Indication, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Source, Indication, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Source, Indication, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Source, Indication, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axol Bioscience Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellcolabs Clinical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Applications Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynata Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orgenesis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stempeutics Research Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioRestorative Therapies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTime Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PLURI Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Tech Pharmed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations